Augusto C. Ochoa’s introduction to NCI community research had the feel of a battlefield commission. In the aftermath of the 2005 Hurricane Katrina, the PI of what was then the Community Clinical Oncology Program informed Ochoa, that she would be leaving Louisiana State University.
As NCI prepares for a transition of leadership, Acting Director Douglas Lowy is setting out an agenda focused on multi-cancer detection tests, undruggable targets, cell therapy, and on eliminating disparities caused by persistent poverty.
Kansas Governor Laura Kelly has proclaimed September “Comprehensive Cancer Centers Awareness Month” in recognition of The University of Kansas Cancer Center becoming designated as a Comprehensive Cancer Center by NCI.
NCI will award $23 million to four academic institutions to establish centers of excellence that will conduct research on the role of telehealth in delivering cancer-related health care, a practice that became more prevalent during the COVID-19 pandemic.
President Joe Biden has announced his intent to appoint Monica Bertagnolli as the 16th director of the National Cancer Institute—and the first woman and first chair of a clinical trials cooperative group to be named to the role.
It’s been a hot summer all over the world, but our work doesn’t stop as our problems need solutions.
The scene opens with a group of four musicians sitting on couches around a table in a studio. One of them is strumming aimlessly on his guitar, trying out various chords in sequences. Some of it sounds okay, even pleasant; other parts don’t work and are discarded.
The Wistar Institute’s Ellen and Ronald Caplan Cancer Center received a merit extension award totaling more than $5 million from NCI.
Researchers at Baylor College of Medicine have received a five-year, $5.5 million-plus grant from NCI for research on liver cancer risk factors and prevention, with the goal of reducing the burden of liver cancer in patients with metabolic dysfunction.
Monica M. Bertagnolli, a professor of surgery at Harvard Medical School, stands poised to become the first woman and the first chair of a clinical trials cooperative group to be named director of the National Cancer Institute.